Pregled bibliografske jedinice broj: 296866
CSF tau proteins in evaluation of patients with suspected dementia
CSF tau proteins in evaluation of patients with suspected dementia // Neurodegenerative Diseases Vol. 4 (Suppl. 1). 8th International Conference AD/PD Alzheimer's and Parkinson's Diseases: Progress and New Perspectives : Abstracts / Fisher, A ; Hanin, I ; Poewe W ; Windisch, M (ur.).
Basel: Karger Publishers, 2007. str. 135-136 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 296866 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
CSF tau proteins in evaluation of patients with suspected dementia
Autori
Šimić, Goran ; Boban, Marina ; Šarac, Helena ; Grbić, Kristina ; Hof, Patrick ; Hamann, Christine ; Ackl, Nibal ; Bader, Benedikt ; Danek, Adrian
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Neurodegenerative Diseases Vol. 4 (Suppl. 1). 8th International Conference AD/PD Alzheimer's and Parkinson's Diseases: Progress and New Perspectives : Abstracts
/ Fisher, A ; Hanin, I ; Poewe W ; Windisch, M - Basel : Karger Publishers, 2007, 135-136
ISBN
3-8055-8282-7
Skup
8th International Conference AD/PD Alzheimer's and Parkinson's Diseases: Progress and New Perspectives
Mjesto i datum
Salzburg, Austrija, 14.03.2007. - 18.03.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Alzheimer's disease; cerebrospinal fluid; early diagnosis; tau proteins; frontotemporal dementia; vascular dementia; Lewy-body disease; Creutzfeld-Jacob disease
Sažetak
We tried to evaluate the diagnostic value of CSF total tau protein (t-tau), tau protein phosphorylated at threonine 181 and serine 199 (p-tau181 and p-tau199) in early-onset Alzheimer's disease (AD) versus healthy controls (HC) and other primary causes of dementia, such as frontotemporal dementia (FTD), vascular dementia (VaD), diffuse Lewy-body disease (DLBD) and Creutzfeld-Jacob disease (CJD). CSF levels were measured using commercially available ELISA kits (t-tau and p-tau199 - BioSource, Camarillo, CA, USA and p-tau181 - Innogenetics, Ghent, Belgium). Mean CSF t-tau and CSF p-tau181 levels were significantly elevated in AD patients compared to FTD, VaD and HC. P-tau181 showed best sensitivity and specificity for AD vs DLB (sens. 91%, spec. 94%), t-tau for AD vs VaD (sens. 91%, spec. 95%), while p-tau199 showed low specificity (25-30% when sensitivity was set at 85% or greater). We concluded that total tau and p-tau181 represent useful biological markers for distinguishing AD from other primary causes of dementia, suggesting that CSF examination of tau proteins should become a part of routine diagnostic procedure for patients with suspected dementia.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Psihologija
Napomena
Sažetak rada je tiskan u časopisu Neurodegenerative Diseases 2007 Vol. 4 (Suppl. 1): 135-136. Ovaj časopis se redovito indeksira u Current Contents i Index Medicus/Medline, a sam članak je indeksiran u Science Citation Index expanded.
POVEZANOST RADA
Projekti:
108-1081870-1942 - Fosforilacija tau proteina u razvitku i Alzheimerovoj bolesti (Šimić, Goran, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE